SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEKÂ 445.40
arrow_upward
+2.39%(+10.40) 1D
Jun 4, 5:29:48 PM GMT+2 · SEK
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEKÂ 434.00
High
SEKÂ 445.80
Low
SEKÂ 433.40
Mkt. cap
159.19B
Avg. vol.
459.72K
Volume
785.20K
P/E ratio
182.59
52-wk high
SEKÂ 451.80
52-wk low
SEKÂ 261.20
EPS
SEKÂ 2.44
Shares outstanding
357.41M
No. of employees
2K
Open
SEKÂ 434.00
High
SEKÂ 445.80
Low
SEKÂ 433.40
Mkt. cap
159.19B
Avg. vol.
459.72K
Volume
785.20K
P/E ratio
182.59
52-wk high
SEKÂ 451.80
52-wk low
SEKÂ 261.20
EPS
SEKÂ 2.44
Shares outstanding
357.41M
No. of employees
2K
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to SOBI in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for SOBI in the last 3 months.
Highest
Current SEKÂ 445.40
SEKÂ 550.00 (+23.48%)
Average
SEKÂ 475.00 (+6.65%)
Lowest
SEKÂ 350.00 (-21.42%)
News stories
From sources across the web
Simply Wall Street
·
5 minutes ago
Dyne Therapeutics DM1 Trial Reaches Pivotal Stage With ACHIEVE Enrollment
Blockhead
·
27 minutes ago
Grayscale Launches HYPG on Nasdaq, Entering a Three-Way Fee War for Hyperliquid ETF Assets
JHNewsAndGuide.com
·
31 minutes ago
The Dow leaps to a record as oil prices ease and US stocks outside of AI rally
Profile
Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden.
In 2020 it had a revenue of SEK 15.261 billion and 1,509 employees. Wikipedia
About Swedish Orphan Biovitrum AB (publ)
AI content may include mistakes. Learn more